BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 19864091)

  • 1. Inner ear involvement in Behçet's disease.
    Süslü AE; Polat M; Köybaşi S; Biçer YO; Funda YO; Parlak AH
    Auris Nasus Larynx; 2010 Jun; 37(3):286-90. PubMed ID: 19864091
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of cochlear involvement by distortion product otoacoustic emission in Behçet's disease.
    Dagli M; Eryilmaz A; Tanrikulu S; Aydin A; Gonul M; Gul U; Gocer C
    Auris Nasus Larynx; 2008 Sep; 35(3):333-7. PubMed ID: 17996415
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Distortion product otoacoustic emission findings in Behçet's disease and rheumatoid arthritis.
    Bayazit YA; Yilmaz M; Gunduz B; Altinyay S; Kemaloglu YK; Onder M; Gurer MA
    ORL J Otorhinolaryngol Relat Spec; 2007; 69(4):233-8. PubMed ID: 17409782
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hearing loss in patients with Behçet's disease: an audiological and transient evoked otoacoustic emission study.
    Aslan S; Serarslan G; Savas N; Teksoz E; Dagli S
    J Laryngol Otol; 2010 Jan; 124(1):10-5. PubMed ID: 19785925
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Effect of inner ear hearing loss on delayed otoacoustic emissions (TEOAE) and distortion products (DPOAE)].
    Hoth S
    Laryngorhinootologie; 1996 Dec; 75(12):709-18. PubMed ID: 9081275
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Outer hair cell activity of the cochlea in patients with iron deficiency anemia.
    Cetin T; Yetiser S; Cekin E; Durmus C; Nevruz O; Oktenli C
    Auris Nasus Larynx; 2004 Dec; 31(4):389-94. PubMed ID: 15571912
    [TBL] [Abstract][Full Text] [Related]  

  • 7. DPOAE in estimation of the function of the cochlea in tinnitus patients with normal hearing.
    Sztuka A; Pospiech L; Gawron W; Dudek K
    Auris Nasus Larynx; 2010 Feb; 37(1):55-60. PubMed ID: 19560298
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Distortion product otoacoustic emissions in an industrial setting.
    Korres GS; Balatsouras DG; Tzagaroulakis A; Kandiloros D; Ferekidou E; Korres S
    Noise Health; 2009; 11(43):103-10. PubMed ID: 19414930
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cochlear involvement in Familial Mediterranean Fever: a new feature of an old disease.
    Koybasi S; Atasoy Hİ; Bicer YO; Tug E
    Int J Pediatr Otorhinolaryngol; 2012 Feb; 76(2):244-7. PubMed ID: 22177320
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of cochlear hearing disorders: normative distortion product otoacoustic emission measurements.
    Mills DM; Feeney MP; Gates GA
    Ear Hear; 2007 Dec; 28(6):778-92. PubMed ID: 17982366
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Applying distortion product otoacoustic emission in testing human sensory hearing loss].
    Chen X; Zheng H; Zheng Y
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2004 May; 35(3):382-4. PubMed ID: 15181843
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cochlear origin of early hearing loss in vestibular schwannoma.
    Gouveris HT; Victor A; Mann WJ
    Laryngoscope; 2007 Apr; 117(4):680-3. PubMed ID: 17429875
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Distortion-product otoacoustic emissions and cochlear microphonics: relationships in patients with and without endolymphatic hydrops.
    Fetterman BL
    Laryngoscope; 2001 Jun; 111(6):946-54. PubMed ID: 11404602
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quantitative analysis of cochlear active mechanisms in tinnitus subjects with normal hearing sensitivity: multiparametric recording of evoked otoacoustic emissions and contralateral suppression.
    Paglialonga A; Del Bo L; Ravazzani P; Tognola G
    Auris Nasus Larynx; 2010 Jun; 37(3):291-8. PubMed ID: 19879078
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Otoacoustic emissions in patients with hypotension.
    Balatsouras DG; Korres S; Simaskos N; Kandiloros D; Ferekidis E; Economou C
    J Laryngol Otol; 2003 Apr; 117(4):265-9. PubMed ID: 12816214
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Distortion-product otoacoustic emission spectra and high-resolution audiometry in noise-induced hearing loss.
    Avan P; Bonfils P
    Hear Res; 2005 Nov; 209(1-2):68-75. PubMed ID: 16112827
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An objective method of analyzing cochlear versus noncochlear patterns of distortion-product otoacoustic emissions in patients with acoustic neuromas.
    Telischi F
    Laryngoscope; 2000 Apr; 110(4):553-62. PubMed ID: 10763999
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cochlear function in facioscapulohumeral muscular dystrophy.
    Balatsouras DG; Korres S; Manta P; Panousopoulou A; Vassilopoulos D
    Otol Neurotol; 2007 Jan; 28(1):7-10. PubMed ID: 17106430
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Behçet's disease and hearing loss.
    AK E; Harputluoglu U; Oghan F; Baykal B
    Auris Nasus Larynx; 2004 Mar; 31(1):29-33. PubMed ID: 15041051
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Studies of the evaluation of cochlea function with distortion product otoacoustic emission].
    Kashiwamura M
    Hokkaido Igaku Zasshi; 1998 Nov; 73(6):641-62. PubMed ID: 10036620
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.